When evidence says no: gynaecologists' reasons for (not) recommending ineffective ovarian cancer screening

被引:7
|
作者
Wegwarth, Odette [1 ]
Pashayan, Nora [2 ]
机构
[1] Max Planck Inst Human Dev, Harding Ctr Risk Literacy, Ctr Adapt Rational, Berlin, Germany
[2] UCL, Inst Epidemiol & Healthcare, Dept Appl Hlth Res, London, England
关键词
evidence-based medicine; medical education; continuing education; continuing professional development; decision making; patient safety; PHYSICIANS; MORTALITY; CLAIMS;
D O I
10.1136/bmjqs-2019-009854
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
[No abstract available]
引用
收藏
页码:521 / 524
页数:4
相关论文
共 39 条
  • [21] Evidence for population-based BRCA1 and BRCA2 screening for ovarian cancer prevention
    Levy-Lahad, E.
    Gabai-Kapara, E.
    Kaufman, B.
    Catane, R.
    Segev, S.
    Renbaum, P.
    Beller, U.
    King, M. C.
    Lahad, A.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2012, 22 : S43 - S43
  • [22] The value of explicitly emulating a target trial when using real world evidence: an application to colorectal cancer screening
    Xabier García-Albéniz
    John Hsu
    Miguel A. Hernán
    European Journal of Epidemiology, 2017, 32 : 495 - 500
  • [23] Why is prostate cancer screening so common when the evidence is so uncertain? A system without negative feedback
    Ransohoff, DF
    McNaughton Collins, M
    Fowler, FJ
    AMERICAN JOURNAL OF MEDICINE, 2002, 113 (08): : 663 - 667
  • [24] The value of explicitly emulating a target trial when using real world evidence: an application to colorectal cancer screening
    Garcia-Albeniz, Xabier
    Hsu, John
    Hernan, Miguel A.
    EUROPEAN JOURNAL OF EPIDEMIOLOGY, 2017, 32 (06) : 495 - 500
  • [26] Emerging Concerns When Evidence-Based Medicine Is Translated into Real Life: The Case of Neoadjuvant Chemotherapy in Ovarian Cancer
    Gonzalez-Martin, Antonio
    Chiva, Luis
    CURRENT ONCOLOGY REPORTS, 2013, 15 (01) : 4 - 6
  • [27] Emerging Concerns When Evidence-Based Medicine Is Translated into Real Life: The Case of Neoadjuvant Chemotherapy in Ovarian Cancer
    Antonio González-Martín
    Luis Chiva
    Current Oncology Reports, 2013, 15 : 4 - 6
  • [28] When Should Guidelines Change? A Clarion Call for Evidence Regarding the Benefits and Risks of Screening for Colorectal Cancer at Earlier Ages
    Corley, Douglas A.
    Peek, Richard M., Jr.
    GASTROENTEROLOGY, 2018, 155 (04) : 947 - 949
  • [29] US gynecologists’ estimates and beliefs regarding ovarian cancer screening’s effectiveness 5 years after release of the PLCO evidence
    Odette Wegwarth
    Gerd Gigerenzer
    Scientific Reports, 8
  • [30] US gynecologists' estimates and beliefs regarding ovarian cancer screening's effectiveness 5 years after release of the PLCO evidence
    Wegwarth, Odette
    Gigerenzer, Gerd
    SCIENTIFIC REPORTS, 2018, 8